Search results
Investors might be losing patience for BioCryst Pharmaceuticals' (NASDAQ:BCRX) increasing losses, as...
Simply Wall St. via Yahoo Finance· 2 years agoInvesting can be hard but the potential fo an individual stock to pay off big time inspires us. But...
Why BioCryst Pharmaceuticals Topped the Market Today
Motley Fool· 2 years agoBioCryst Pharmaceuticals (NASDAQ: BCRX) stock defied the market's gravity on Wednesday by rising incrementally. Although it was a challenging day for stocks in general, with the S&P 500 index ...
Why Shares of BioCryst Pharmaceuticals Jumped Today
Motley Fool· 1 year agoShares of BioCryst Pharmaceuticals (NASDAQ: BCRX) were up 12% Wednesday afternoon, a day after the commercial-stage biotech released full-year and...
Hidden Penny Gems: 7 Stocks With Triple-Digit Growth Prospects
InvestorPlace via Yahoo Finance· 3 months agoEach of these hidden penny stock gems have the potential to provide triple digit growth to...
BioCryst Pharmaceuticals 'Fantastic' Q1 Earnings Rides On Outstanding Orladeyo Performance
Benzinga via Yahoo Finance· 3 weeks agoMonday, BioCryst Pharmaceuticals Inc (NASDAQ:BCRX) reported a first-quarter earnings loss of $(0.17)...
Why BioCryst Pharmaceuticals Stock Is Bolting Higher Today
Motley Fool· 2 years agoShares of the rare disease specialist BioCryst Pharmaceuticals (NASDAQ: BCRX) were up by a noteworthy 20% on heavy volume at 9:38 a.m. ET Thursday morning. Although the biotech reported encouraging ...
2 Biotech Stocks You'll Regret Not Buying on the Dip
Motley Fool· 2 years agoBiotech stocks were among the first group of equities to head southward late last year. The closely watched iShares Biotechnology ETF and SPDR S&P...
3 Fast-Growing Stocks to Buy Now
Motley Fool· 2 years agoIt's really exciting to see triple-digit revenue growth. ShockWave Medical (NASDAQ: SWAV) and BioCryst Pharmaceuticals (NASDAQ: BCRX) are blowing the roof off right now, with 194% and 162% sales increases, respectively.